Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	42.39	91.51	64.27
Graham Fair Price	-28.02	11.11	15.44
PEG	-89.69	-0.82	7.98
Price/Book	-18.73	3.44	4.23
Price/Cash Flow	48.72	60.75	40.85
Prices/Earnings	70.09	41.15	24.19
Price/Sales	-13.03	8.83	10.16
Price/FCF	48.72	60.75	40.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.07	0.31	0.33
Operating Margin	-46.46	0.08	0.15
ROA	-51.11	0.01	0.02
ROE	0.04	0.02	-52.22
ROIC	0.02	0.01	-49.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	97.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.02	-0.48	2461.53
EPS QOQ	0.03	-0.50	1550.00
FCF QOQ	1.48	-0.43	-71.02
Revenue QOQ	-0.01	-0.02	-126.59
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	72.96	71.83	-1.55
Inventory Turnover	147624000.00	0.00	inf
Debt/Capitalization	0.43	0.42	-2.42
Quick Ratio	3.92	4.24	7.94
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.57	16.22	4.13
Cash	3.78	4.15	9.68
Capex	< 0.005	-0.02	-101.40
Free Cash Flow	1.61	0.92	-43.10
Revenue	6.48	6.30	-2.70
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.15	4.18	0.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.23	12.37	70.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating